Cargando…

Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia

PURPOSE: Although visual deficits can be observed at any stage of schizophrenia, few studies have focused on visual cortex alterations in individuals at high risk of schizophrenia. This study aimed to investigate the pathological changes of the primary visual cortex in a prenatal mouse model of MK80...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xinying, Chen, Ce, Ji, Feng, Xu, Yong, Wang, Wenqiang, Lin, Xiaodong, Jiang, Deguo, Song, Xueqin, Gao, Xiangyang, Tian, Hongjun, Zhuo, Chuanjun, Zhang, Jingliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853429/ https://www.ncbi.nlm.nih.gov/pubmed/33542631 http://dx.doi.org/10.2147/NDT.S246163

Ejemplares similares

Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions
por: Zhuo, Chuanjun, et al.
Publicado: (2023)

The rise and fall of MRI studies in major depressive disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Exploration of the cortical pathophysiology underlying visual disturbances in schizophrenia comorbid with depressive disorder—An evidence from mouse model
por: Liu, Jian, et al.
Publicado: (2021)

Abberant inverted U-shaped brain pattern and trait-related retinal impairment in schizophrenia patients with combined auditory and visual hallucinations: a pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Adjunct ketamine treatment of depression in treatment‐resistant schizophrenia patients is unsatisfactory in pilot and secondary follow‐up studies
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment‐resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Transcranial direct current stimulation of the occipital lobes with adjunct lithium attenuates the progression of cognitive impairment in patients with first episode schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale
por: Du, Chenyuan, et al.
Publicado: (2022)

A unified model of shared brain structural alterations in patients with different mental disorders who experience own‐thought auditory verbal hallucinations—A pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Functional brain alterations in auditory hallucination subtypes in individuals with auditory hallucinations without the diagnosis of specific neurological diseases and mental disorders at the current stage
por: Lin, Xiaodong, et al.
Publicado: (2019)

Global functional connectivity density alterations in patients with bipolar disorder with auditory verbal hallucinations and modest short‐term effects of transcranial direct current stimulation augmentation treatment—Baseline and follow‐up study
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow‐up study
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2023)

Validity and reliability of a Chinese version of the Bergen Work Addiction Scale
por: Liu, Yuanyuan, et al.
Publicado: (2023)

Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment
por: Ye, Jiaen, et al.
Publicado: (2019)

Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model
por: Zhou, Chunhua, et al.
Publicado: (2020)

Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2017)

Distinct pattern of cerebral blood flow alterations specific to schizophrenics experiencing auditory verbal hallucinations with and without insight: a pilot study
por: Jing, Rixing, et al.
Publicado: (2017)

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain Cancer
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Brain imaging features in schizophrenia with co‐occurring auditory verbal hallucinations and depressive symptoms—Implication for novel therapeutic strategies to alleviate the reciprocal deterioration
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2017)

Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up study
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Anxiety and clinical outcomes of patients with acute coronary syndrome: a meta-analysis
por: Li, Jie, et al.
Publicado: (2020)

Diffusion Tensor MR Imaging Evaluation of Callosal Abnormalities in Schizophrenia: A Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2016)

Lipidomics of the brain, retina, and biofluids: from the biological landscape to potential clinical application in schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Validity and reliability of a Chinese version of the self‐evaluation of negative symptoms
por: Chen, Guangdong, et al.
Publicado: (2023)

Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Brain features of nearly drug‐naïve female monozygotic twins with first‐episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study
por: Zhang, Tao, et al.
Publicado: (2020)

A borderline personality assessment for adolescents: Validity and reliability of the Chinese languages borderline personality features scale (short form version) for adolescents/children
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Without insight accompanied with deteriorated brain functional alterations in healthy individuals with auditory verbal hallucinations: a pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Functional connectivity density alterations in schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2014)

Lung cancer incidence in patients with schizophrenia: meta-analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Sexual life satisfaction and its associated socio-demographic and workplace factors among Chinese female nurses of tertiary general hospitals
por: Ji, Feng, et al.
Publicado: (2017)

Brain structural and functional dissociated patterns in schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2017)

Aberrant patterns of local and long-range functional connectivity densities in schizophrenia
por: Liu, Chuanxin, et al.
Publicado: (2017)

The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option
por: Lv, Fengli, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aqeaisv5mp1hm6csuli7afu9jl